Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin L Stephans

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Journal of Gastrointestinal Cancer|October 14, 2016
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative OutcomesMichael J McNamara, David J Adelstein, Daniela S Allende, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimenMichael J McNamara, Lisa A Rybicki, Davendra Sohal, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
Journal of Radiosurgery and SBRT|April 26, 2021
Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experienceTimothy D Smile, Chandana A Reddy, George Qiao-Guan, et al.
The Journal of Clinical Investigation|November 15, 2023
Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancerShinjini Ganguly, Zaeem Lone, Andrew Muskara, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated PatientsRitchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2015
Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic ModelAlexander V Louie, Cornelis J A Haasbeek, Sahar Mokhles, et al.
Advances in Radiation Oncology|June 13, 2020
Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerAudrey T Dang, Rebecca G Levin-Epstein, David Shabsovich, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Journal of Gastrointestinal Cancer|October 14, 2016
Persistent Dysphagia After Induction Chemotherapy in Patients with Esophageal Adenocarcinoma Predicts Poor Post-Operative OutcomesMichael J McNamara, David J Adelstein, Daniela S Allende, et al.
Journal of Gastrointestinal Oncology|April 2, 2016
The relationship between pathologic nodal disease and residual tumor viability after induction chemotherapy in patients with locally advanced esophageal adenocarcinoma receiving a tri-modality regimenMichael J McNamara, Lisa A Rybicki, Davendra Sohal, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2014
Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelinesTheodore S Hong, Walter R Bosch, Sunil Krishnan, et al.
Journal of Radiosurgery and SBRT|April 26, 2021
Stereotactic body radiotherapy for the treatment of oligometastatic gynecological malignancy in the abdomen and pelvis: A single-institution experienceTimothy D Smile, Chandana A Reddy, George Qiao-Guan, et al.
The Journal of Clinical Investigation|November 15, 2023
Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancerShinjini Ganguly, Zaeem Lone, Andrew Muskara, et al.
International Journal of Radiation Oncology, Biology, Physics|January 25, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated PatientsRitchell van Dams, Naomi Y Jiang, Donald B Fuller, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2015
Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic ModelAlexander V Louie, Cornelis J A Haasbeek, Sahar Mokhles, et al.
Advances in Radiation Oncology|June 13, 2020
Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate CancerAudrey T Dang, Rebecca G Levin-Epstein, David Shabsovich, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
Pageof 9